These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12823911)

  • 1. Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.
    Geller D; Thipphawong J; Otulana B; Caplan D; Ericson D; Milgram L; Okikawa J; Quan J; Bowman CM
    J Aerosol Med; 2003; 16(2):175-82. PubMed ID: 12823911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.
    Fiel SB; Fuchs HJ; Johnson C; Gonda I; Clark AR
    Chest; 1995 Jul; 108(1):153-6. PubMed ID: 7606951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
    N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
    Aitken ML; Burke W; McDonald G; Shak S; Montgomery AB; Smith A
    JAMA; 1992 Apr; 267(14):1947-51. PubMed ID: 1548827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Ramsey BW; Astley SJ; Aitken ML; Burke W; Colin AA; Dorkin HL; Eisenberg JD; Gibson RL; Harwood IR; Schidlow DV
    Am Rev Respir Dis; 1993 Jul; 148(1):145-51. PubMed ID: 8317790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
    Henry RL; Gibson PG; Carty K; Cai Y; Francis JL
    Pediatr Pulmonol; 1998 Aug; 26(2):97-100. PubMed ID: 9727759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
    Harms HK; Matouk E; Tournier G; von der Hardt H; Weller PH; Romano L; Heijerman HG; FitzGerald MX; Richard D; Strandvik B; Kolbe J; Kraemer R; Michalsen H
    Pediatr Pulmonol; 1998 Sep; 26(3):155-61. PubMed ID: 9773909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.
    Johnson JC; Waldrep JC; Guo J; Dhand R
    Respir Care; 2008 Dec; 53(12):1703-8. PubMed ID: 19025706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
    Suri R
    BioDrugs; 2005; 19(3):135-44. PubMed ID: 15984899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Hemming AL; Moriarty C; Eberl S; Bye PT
    Pediatr Pulmonol; 2000 Jul; 30(1):16-24. PubMed ID: 10862158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S
    Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
    Shah PI; Bush A; Canny GJ; Colin AA; Fuchs HJ; Geddes DM; Johnson CA; Light MC; Scott SF; Tullis DE
    Eur Respir J; 1995 Jun; 8(6):954-8. PubMed ID: 7589382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
    Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
    van der Giessen LJ; Gosselink R; Hop WC; Tiddens HA
    Eur Respir J; 2007 Oct; 30(4):763-8. PubMed ID: 17596273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of two aerosol delivery systems for rhDNase.
    Shah PL; Scott SF; Geddes DM; Conway S; Watson A; Nazir T; Carr SB; Wallis C; Marriott C; Hodson ME
    Eur Respir J; 1997 Jun; 10(6):1261-6. PubMed ID: 9192926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
    Wilmott RW; Amin RS; Colin AA; DeVault A; Dozor AJ; Eigen H; Johnson C; Lester LA; McCoy K; McKean LP; Moss R; Nash ML; Jue CP; Regelmann W; Stokes DC; Fuchs HJ
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1914-7. PubMed ID: 8665055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhDNase I aerosol deposition and related factors in cystic fibrosis.
    Diot P; Palmer LB; Smaldone A; DeCelie-Germana J; Grimson R; Smaldone GC
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1662-8. PubMed ID: 9372691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
    Suri R; Metcalfe C; Lees B; Grieve R; Flather M; Normand C; Thompson S; Bush A; Wallis C
    Lancet; 2001 Oct; 358(9290):1316-21. PubMed ID: 11684212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhDNase before airway clearance therapy improves airway patency in children with CF.
    van der Giessen LJ; de Jongste JC; Gosselink R; Hop WC; Tiddens HA
    Pediatr Pulmonol; 2007 Jul; 42(7):624-30. PubMed ID: 17534979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.